Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 224 participants.

Also called NCT05459974

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 224 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05459974
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05459974. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-20 (actual); primary completion 2023-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation
Intervention (Drug)
Colchicine 0.6 mg
Intervention (Drug)
Placebo
Lead sponsor
Stony Brook University (class: other)

Record details

Record id
cardio:ct-nct05459974
Content hash
d7c01a5c26f5e47fe8b49c771ecde520a8158f80b49bfd1201a1fb470cac03dd